查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867499

次世代定序(NGS) 服務：全球市場佔有率和排名、總收入和需求預測 (2025-2031)

Next-Generation Sequencing (NGS) Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球次世代定序(NGS) 服務市場預計在 2024 年達到 212.41 億美元，預計到 2031 年將達到 650.46 億美元，2025 年至 2031 年的複合年成長率為 16.4%。

次世代定序（NGS）服務是指基於高通量定序平台的綜合性基因分析解決方案，能夠從多個層面檢測和分析基因組、轉錄組和表觀基因資訊。 NGS利用並行化、大規模、高精度的定序技術，顯著提高了基因資料收集的效率和準確性，單次運行即可產生大量的DNA或RNA序列資料集。這些服務涵蓋整個工作流程，包括樣本製備、文庫建構、定序操作、資料處理和生物資訊分析，並為包括科學研究、臨床診斷、藥物研發、農業育種和微生物學研究在內的各種需求提供客製化解決方案。憑藉其成本效益高、數據深度廣、應用範圍廣等優勢，NGS服務已成為精準醫療、生命科學和生物技術產業的重要平台技術和創新驅動力。

全球精準醫療策略的加速推進和生物資訊學的不斷進步，為新一代定序（NGS）服務市場創造了巨大的成長機會。政府對基因組研究和臨床應用計劃（例如早期癌症篩檢）的投入不斷增加，推動了醫院、研究機構和生物製藥公司對NGS服務的需求成長。隨著定序成本的顯著降低和周轉時間的縮短，NGS已從探索性研究轉向大規模臨床應用，涵蓋腫瘤譜分析、伴隨診斷、病原體檢測和罕見疾病篩檢等領域。平台技術供應商、服務提供者和下游應用領域之間價值鏈的深度合作，正在加速新型服務模式和增值應用的普及。

儘管NGS服務市場發展迅速，但仍面臨許多挑戰，例如缺乏標準化的資料解讀通訊協定、臨床應用監管要求嚴格以及與資料安全相關的合規風險。國家和地區間的監管差異也增加了跨境營運的複雜性。高品質的生物資訊分析需要經驗豐富的技術團隊和強大的運算基礎設施，這構成了准入門檻。某些細分領域定序的準確性和靈敏度要求極高，因此需要持續投入研發和品管。此外，在市場競爭日益激烈的背景下，如何在價格壓力下提供差異化的服務能力，已成為企業永續性和擴張的關鍵考驗。

未來幾年，NGS服務的下游需求將更加多元化，並跨越多個領域進行整合。在醫療保健領域，個人化治療和疾病早期篩檢將持續擴展，尤其是在癌症、感染疾病和遺傳疾病的精準診斷方面。在生物製藥產業，NGS將在新藥標靶發現、藥物反應機制闡明以及臨床試驗中的患者分層方面發揮關鍵作用。在農業和環境科學領域，NGS技術將擴大應用於作物改良、動物育種和微生物組監測。同時，人工智慧驅動的自動化分析和雲端基礎的資料整合將提升NGS服務的效率並促進其廣泛應用，從而滿足科學研究和工業應用對即時、大規模、多維度遺傳資訊日益成長的需求。

本報告旨在按地區/國家、類型和應用對全球次世代定序(NGS) 服務市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以銷售收入為指標，對次世代定序(NGS) 服務市場規模、估算和預測進行了闡述，基準年為 2024 年，並涵蓋了 2020 年至 2031 年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定次世代定序(NGS) 服務的業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Thermo Fisher Scientific
  • Macrogen
  • Oxford Nanopore
  • Novogene
  • Pacific Biosciences
  • Azenta Life Sciences

按類型分類的細分市場

  • 標靶定序
  • 全外EXOME定序
  • 全基因測序

應用領域

  • 醫院和診所
  • 生物製藥公司
  • 學術和研究機構
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Next-Generation Sequencing (NGS) Services was estimated to be worth US$ 21241 million in 2024 and is forecast to a readjusted size of US$ 65046 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.

Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.

The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.

Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.

In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Sequencing (NGS) Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next-Generation Sequencing (NGS) Services by region & country, by Type, and by Application.

The Next-Generation Sequencing (NGS) Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Sequencing (NGS) Services.

Market Segmentation

By Company

  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Thermo Fisher Scientific
  • Macrogen
  • Oxford Nanopore
  • Novogene
  • Pacific Biosciences
  • Azenta Life Sciences

Segment by Type

  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing

Segment by Application

  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Next-Generation Sequencing (NGS) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Next-Generation Sequencing (NGS) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Next-Generation Sequencing (NGS) Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Next-Generation Sequencing (NGS) Services Product Introduction
  • 1.2 Global Next-Generation Sequencing (NGS) Services Market Size Forecast (2020-2031)
  • 1.3 Next-Generation Sequencing (NGS) Services Market Trends & Drivers
    • 1.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
    • 1.3.2 Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity
    • 1.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
    • 1.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024)
  • 2.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025)
  • 2.3 Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Next-Generation Sequencing (NGS) Services Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services
  • 2.6 Next-Generation Sequencing (NGS) Services Market Competitive Analysis
    • 2.6.1 Next-Generation Sequencing (NGS) Services Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Targeted Sequencing
    • 3.1.2 Whole Exome Sequencing
    • 3.1.3 Whole Genome Sequencing
  • 3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type
    • 3.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (2020-2031)
    • 3.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals and Clinics
    • 4.1.2 Biopharma Companies
    • 4.1.3 Academic & Research Organizations
    • 4.1.4 Others
  • 4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application
    • 4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (2020-2031)
    • 4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region
    • 5.1.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025)
    • 5.1.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031)
    • 5.1.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 5.2.2 North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 5.3.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 5.5.2 South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.3.2 United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.5.2 China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.6.2 Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.7.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
    • 6.9.2 India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Eurofins Scientific
    • 7.1.1 Eurofins Scientific Profile
    • 7.1.2 Eurofins Scientific Main Business
    • 7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Eurofins Scientific Recent Developments
  • 7.2 Natera
    • 7.2.1 Natera Profile
    • 7.2.2 Natera Main Business
    • 7.2.3 Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Natera Recent Developments
  • 7.3 BGI
    • 7.3.1 BGI Profile
    • 7.3.2 BGI Main Business
    • 7.3.3 BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.3.5 BGI Recent Developments
  • 7.4 Illumina
    • 7.4.1 Illumina Profile
    • 7.4.2 Illumina Main Business
    • 7.4.3 Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Illumina Recent Developments
  • 7.5 Roche
    • 7.5.1 Roche Profile
    • 7.5.2 Roche Main Business
    • 7.5.3 Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Roche Recent Developments
  • 7.6 LabCorp
    • 7.6.1 LabCorp Profile
    • 7.6.2 LabCorp Main Business
    • 7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.6.5 LabCorp Recent Developments
  • 7.7 Berry Genomics
    • 7.7.1 Berry Genomics Profile
    • 7.7.2 Berry Genomics Main Business
    • 7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Berry Genomics Recent Developments
  • 7.8 Thermo Fisher Scientific
    • 7.8.1 Thermo Fisher Scientific Profile
    • 7.8.2 Thermo Fisher Scientific Main Business
    • 7.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Thermo Fisher Scientific Recent Developments
  • 7.9 Macrogen
    • 7.9.1 Macrogen Profile
    • 7.9.2 Macrogen Main Business
    • 7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Macrogen Recent Developments
  • 7.10 Oxford Nanopore
    • 7.10.1 Oxford Nanopore Profile
    • 7.10.2 Oxford Nanopore Main Business
    • 7.10.3 Oxford Nanopore Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.10.4 Oxford Nanopore Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Oxford Nanopore Recent Developments
  • 7.11 Novogene
    • 7.11.1 Novogene Profile
    • 7.11.2 Novogene Main Business
    • 7.11.3 Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Novogene Recent Developments
  • 7.12 Pacific Biosciences
    • 7.12.1 Pacific Biosciences Profile
    • 7.12.2 Pacific Biosciences Main Business
    • 7.12.3 Pacific Biosciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.12.4 Pacific Biosciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Pacific Biosciences Recent Developments
  • 7.13 Azenta Life Sciences
    • 7.13.1 Azenta Life Sciences Profile
    • 7.13.2 Azenta Life Sciences Main Business
    • 7.13.3 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
    • 7.13.4 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Azenta Life Sciences Recent Developments

8 Industry Chain Analysis

  • 8.1 Next-Generation Sequencing (NGS) Services Industrial Chain
  • 8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Next-Generation Sequencing (NGS) Services Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Next-Generation Sequencing (NGS) Services Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Next-Generation Sequencing (NGS) Services Market Trends
  • Table 2. Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity
  • Table 3. Next-Generation Sequencing (NGS) Services Market Challenges
  • Table 4. Next-Generation Sequencing (NGS) Services Market Restraints
  • Table 5. Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Next-Generation Sequencing (NGS) Services Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services
  • Table 10. Global Next-Generation Sequencing (NGS) Services Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Next-Generation Sequencing (NGS) Services Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Next-Generation Sequencing (NGS) Services Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Next-Generation Sequencing (NGS) Services Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Next-Generation Sequencing (NGS) Services Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Next-Generation Sequencing (NGS) Services Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Next-Generation Sequencing (NGS) Services Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Next-Generation Sequencing (NGS) Services Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Eurofins Scientific Basic Information List
  • Table 32. Eurofins Scientific Description and Business Overview
  • Table 33. Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Eurofins Scientific (2020-2025)
  • Table 35. Eurofins Scientific Recent Developments
  • Table 36. Natera Basic Information List
  • Table 37. Natera Description and Business Overview
  • Table 38. Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Natera (2020-2025)
  • Table 40. Natera Recent Developments
  • Table 41. BGI Basic Information List
  • Table 42. BGI Description and Business Overview
  • Table 43. BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of BGI (2020-2025)
  • Table 45. BGI Recent Developments
  • Table 46. Illumina Basic Information List
  • Table 47. Illumina Description and Business Overview
  • Table 48. Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Illumina (2020-2025)
  • Table 50. Illumina Recent Developments
  • Table 51. Roche Basic Information List
  • Table 52. Roche Description and Business Overview
  • Table 53. Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Roche (2020-2025)
  • Table 55. Roche Recent Developments
  • Table 56. LabCorp Basic Information List
  • Table 57. LabCorp Description and Business Overview
  • Table 58. LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of LabCorp (2020-2025)
  • Table 60. LabCorp Recent Developments
  • Table 61. Berry Genomics Basic Information List
  • Table 62. Berry Genomics Description and Business Overview
  • Table 63. Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Berry Genomics (2020-2025)
  • Table 65. Berry Genomics Recent Developments
  • Table 66. Thermo Fisher Scientific Basic Information List
  • Table 67. Thermo Fisher Scientific Description and Business Overview
  • Table 68. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Thermo Fisher Scientific (2020-2025)
  • Table 70. Thermo Fisher Scientific Recent Developments
  • Table 71. Macrogen Basic Information List
  • Table 72. Macrogen Description and Business Overview
  • Table 73. Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Macrogen (2020-2025)
  • Table 75. Macrogen Recent Developments
  • Table 76. Oxford Nanopore Basic Information List
  • Table 77. Oxford Nanopore Description and Business Overview
  • Table 78. Oxford Nanopore Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Oxford Nanopore (2020-2025)
  • Table 80. Oxford Nanopore Recent Developments
  • Table 81. Novogene Basic Information List
  • Table 82. Novogene Description and Business Overview
  • Table 83. Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Novogene (2020-2025)
  • Table 85. Novogene Recent Developments
  • Table 86. Pacific Biosciences Basic Information List
  • Table 87. Pacific Biosciences Description and Business Overview
  • Table 88. Pacific Biosciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Pacific Biosciences (2020-2025)
  • Table 90. Pacific Biosciences Recent Developments
  • Table 91. Azenta Life Sciences Basic Information List
  • Table 92. Azenta Life Sciences Description and Business Overview
  • Table 93. Azenta Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Next-Generation Sequencing (NGS) Services Business of Azenta Life Sciences (2020-2025)
  • Table 95. Azenta Life Sciences Recent Developments
  • Table 96. Key Raw Materials Lists
  • Table 97. Raw Materials Key Suppliers Lists
  • Table 98. Next-Generation Sequencing (NGS) Services Downstream Customers
  • Table 99. Next-Generation Sequencing (NGS) Services Distributors List
  • Table 100. Research Programs/Design for This Report
  • Table 101. Key Data Information from Secondary Sources
  • Table 102. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Next-Generation Sequencing (NGS) Services Product Picture
  • Figure 2. Global Next-Generation Sequencing (NGS) Services Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Next-Generation Sequencing (NGS) Services Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Next-Generation Sequencing (NGS) Services Report Years Considered
  • Figure 5. Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Next-Generation Sequencing (NGS) Services Revenue in 2024
  • Figure 7. Next-Generation Sequencing (NGS) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Targeted Sequencing Picture
  • Figure 9. Whole Exome Sequencing Picture
  • Figure 10. Whole Genome Sequencing Picture
  • Figure 11. Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Next-Generation Sequencing (NGS) Services Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Hospitals and Clinics
  • Figure 14. Product Picture of Biopharma Companies
  • Figure 15. Product Picture of Academic & Research Organizations
  • Figure 16. Product Picture of Others
  • Figure 17. Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Next-Generation Sequencing (NGS) Services Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America Next-Generation Sequencing (NGS) Services Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value (%), (2020-2031)
  • Figure 30. United States Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India Next-Generation Sequencing (NGS) Services Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Next-Generation Sequencing (NGS) Services Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Next-Generation Sequencing (NGS) Services Industrial Chain
  • Figure 52. Next-Generation Sequencing (NGS) Services Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed